Adaptive Biotechnologies Corporation ( ADPT) - Stock Earnings
ADPT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | -20.0 million USD | 70.9 million USD |
| 2026Q2 | -39.8 million USD | 71.6 million USD |
| 2026Q3 | 2.9 million USD | 83.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ADPT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -225.3 million USD | 170.3 million USD |
| 2024 | -159.5 million USD | 179.0 million USD |
| 2025 | -59.5 million USD | 277.0 million USD |
| 2026 Est. | — | — |
ADPT
Price: $29.24
52 week price:
Earnings Per Share: -0.45 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Market Capitalization: 4.8 billion